Carl J. Schaerf

Carl J. Schaerf

Schnader Harrison Segal & Lewis LLP

Contact  |  View Bio  |  RSS

Latest Publications

Share:

Sowing Uncertainty: Navigating Patent Disputes and Antitrust Scrutiny Post King Drug

On June 26, 2015, the Third Circuit issued an opinion in King Drug Co. of Florence, Inc. v. Smithkline Beecham Corp., (Case No. 14-1243). King Drug. The opinion, which already has been extensively commented on and...more

8/6/2015 - ANDA Antitrust Violations Drug Manufacturers FTC v Actavis Generic Drugs GlaxoSmithKline Hatch-Waxman No-AG Agreement Patents Reverse Payment Settlement Agreements Rule-of-Reason Analysis Sherman Act

California Supreme Court Decision in Cipro Highlights the Lack of Predictability in Antitrust Jurisprudence and Counseling

On May 7, 2015, the Supreme Court of California issued an opinion in In re Cipro Cases I & II, a case centered on pay-to-delay settlements between drug makers and generic manufacturers. The Court found the existence of an...more

6/16/2015 - Antitrust Provisions Bayer CA Supreme Court FTC FTC v Actavis Generic Drugs Pay-to-Delay System Pharmaceutical Pharmaceutical Manufacturers Pharmaceutical Patents Prescription Drugs Reverse Payment Settlement Agreements

Supreme Court Holds That CERCLA Preemption Is Inapplicable to Statutes of Repose

The Comprehensive Environmental Response, Compensation, and Liability Act of 1980 (CERCLA), preempts statutes of limitations applicable to state-law tort actions for personal injury or property damage in certain...more

6/13/2014 - CERCLA Contaminated Properties CTS v Waldburger Environmental Liability Environmental Policies Hazardous Substances SCOTUS Statute of Limitations Statute of Repose Water

Despite Delay, Failure to Plead, and Participation in Litigation, Federal Court Enforces Arbitration Clause

Mandatory arbitration clauses have proven to be very powerful weapons employed by businesses to avoid the duration, expense, and often times negative publicity associated with protracted litigation in both federal and state...more

3/17/2014 - Arbitration Mandatory Arbitration Clauses

New York's Highest Court Does Not Recognize Claims for Medical Monitoring – For Now: Using "Phobia" Claims as a Backdoor to...

In Caronia v. Philip Morris USA, Inc., 2013 N.Y. LEXIS 3476, 2013 N.Y. Slip. Op. 8372 (December 17, 2013), the New York Court of Appeals, in a 4-21 decision with sharp and barbed contrasts between majority and dissent, ruled...more

12/24/2013 - Healthcare Medical Monitoring

Does Mutual Pharmaceutical Co., Inc. v. Bartlett Herald the Demise of the "Failure-To-Withdraw" Theory?

In most states that use a “risk utility” test to determine whether a product is “not reasonably safe” (i.e. defective) as designed, an alternative design for the product is generally considered to be a critical element of the...more

7/31/2013 - Design Defects Failure To Warn Mensing Mutual Pharmaceuticals v Bartlett

Does New York Law Contain a Heeding Presumption? It Depends Who You Ask

Few theories of liability are as elusive and difficult to defend against as “failure to warn.” Given the hindsight borne of any accident, it is tempting to suggest, and for a jury to want to believe, that a few simple words...more

12/28/2012 - Burden of Proof Failure To Warn Rebuttable Presumptions Removal

7 Results
|
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.
×